Related Experiment Videos
Immunosuppressive action of Qinghaosu
Scientia Sinica. Series B, Chemical, Biological, Agricultural, Medical & Earth Sciences
|April 1, 1984
Summary
Qinghaosu hemisuccinate (QHS), a derivative of the antimalarial drug Qinghaosu, demonstrates significant immunosuppressive effects. QHS inhibits lymphocyte proliferation in vitro and ex vivo, with observed differences in its in vivo and in vitro actions.
Area of Science:
- Pharmacology
- Immunology
- Medicinal Chemistry
Background:
- Qinghaosu, derived from Artemisia annua Linn, is a potent antimalarial agent.
- A water-soluble derivative, Qinghaosu hemisuccinate (QHS), was developed.
- The potential non-antimalarial effects of QHS require investigation.
Purpose of the Study:
- To investigate the immunosuppressive activity of Qinghaosu hemisuccinate (QHS).
- To characterize the in vitro and in vivo immunosuppressive properties of QHS.
- To explore the mechanisms underlying QHS-induced immunosuppression.
Main Methods:
- In vitro assessment of 3H-thymidine incorporation in mitogen-stimulated mouse spleen cells and human lymphocytes.
- Assessment of spontaneous 3H-thymidine incorporation in mouse thymocytes and leukemia patient blood cells.
- In vivo evaluation using quantitative plaque-forming cell (PFC) assays.
Main Results:
- QHS significantly suppressed in vitro lymphocyte proliferation in response to mitogens.
- QHS inhibited spontaneous DNA synthesis in mouse thymocytes and leukemia cells.
- In vivo studies revealed distinct effects compared to in vitro findings, warranting further investigation.
Conclusions:
- Qinghaosu hemisuccinate exhibits notable immunosuppressive properties.
- The observed immunosuppression varies between in vitro and in vivo experimental models.
- Further research is needed to elucidate the precise mechanisms and clinical implications of QHS immunosuppression.